Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash from Financing Activities: 2009-2012

Historic Cash from Financing Activities for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to $36.8 million.

  • Lexicon Pharmaceuticals' Cash from Financing Activities fell 77.02% to $36.8 million in Q4 2012 from the same period last year, while for Dec 2012 it was $36.4 million, marking a year-over-year decrease of 76.84%. This contributed to the annual value of $238.3 million for FY2024, which is 26.81% up from last year.
  • Lexicon Pharmaceuticals' Cash from Financing Activities amounted to $36.8 million in Q4 2012, which was up 8,947.91% from $407,000 recorded in Q3 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Cash from Financing Activities registered a high of $179.2 million during Q1 2010, and its lowest value of -$19.8 million during Q2 2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Cash from Financing Activities value was -$249,000 (recorded in 2010), while the average stood at $28.0 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 60,343.23% in 2011, then slumped by 211.21% in 2012.
  • Over the past 4 years, Lexicon Pharmaceuticals' Cash from Financing Activities (Quarterly) stood at $54.5 million in 2009, then tumbled by 100.49% to -$266,000 in 2010, then spiked by 60,343.23% to $160.2 million in 2011, then tumbled by 77.02% to $36.8 million in 2012.
  • Its last three reported values are $36.8 million in Q4 2012, $407,000 for Q3 2012, and -$129,000 during Q2 2012.